Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

NCT01508104 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped funding

Conditions

Cancer

Interventions

DRUG: BEZ235
DRUG: Everolimus

Sponsor

University of Cincinnati

Collaborators

[object Object]